양격산화탕과 태음조위탕 추출물의 in vitro CYP450 효소 활성 억제 효과
In vitro inhibitory effects of Yangguksanhwa-tang and Taeumjowi-tang on CYP450 isozymes
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: Herb-drug interactions have become an important issue because of the consumption of herbal remedies has increased in the world. Yangguksanhaw-tang (Liang ge san huo-tang) and Taeumjowi-tang (Tai yin tiao wei-tang) are typical herbal formulas on Sasang constitution medicine (four-constitution medicine). This study was aimed at evaluating the effects of Yangguksanhaw-tang and Taeumjowi-tang on drug metabolizing enzymes, cytochrome P450 (CYP450) isozymes. Methods : VividⓇ CYP450 Screening Kits were used to measure of CYP3A4, CYP2C19, CYP2D6 and CYP2E1 activities. This method is based on the use of fluorescent CYP450 substrates that are efficiently metabolized by specific CYP450 isozymes to yield a product with altered fluorescent properties. The percent inhibitions of CYP450s by herbal formulas were calculated. Results : Yangguksanhaw-tang inhibited CYP2C19 and CYP2E1 activities higher than that other CYP450 isozymes. The IC50 values of CYP2C19 and CYP2E1 were 159.83 μg/mL and 261.40 μg/mL, respectively. The CYP2E1 activity was inhibited (IC50=215.17 μg/mL) higher than that other CYP450 isozymes by Taeumjowi-tang. Conclusions : These results suggest that Yangguksanhaw-tang may inhibit the metabolism of co-administered drugs whose primary route of metabolism is via CYP2C19 or CYP2E1. Taeumjowi-tang could inhibit the metabolism of co-administered drugs, which are substrates for CYP2E1. Therefore, co-administration of the herbal formulas and other conventional drugs should be undertaken with care.
Abstract
Objective: Herb-drug interactions have become an important issue because of the consumption of herbal remedies has increased in the world. Yangguksanhaw-tang (Liang ge san huo-tang) and Taeumjowi-tang (Tai yin tiao wei-tang) are typical herbal formulas on Sasang constitution medicine (four-constitution medicine). This study was aimed at evaluating the effects of Yangguksanhaw-tang and Taeumjowi-tang on drug metabolizing enzymes, cytochrome P450 (CYP450) isozymes. Methods : VividⓇ CYP450 Screening Kits were used to measure of CYP3A4, CYP2C19, CYP2D6 and CYP2E1 activities. This method is based on the use of fluorescent CYP450 substrates that are efficiently metabolized by specific CYP450 isozymes to yield a product with altered fluorescent properties. The percent inhibitions of CYP450s by herbal formulas were calculated. Results : Yangguksanhaw-tang inhibited CYP2C19 and CYP2E1 activities higher than that other CYP450 isozymes. The IC50 values of CYP2C19 and CYP2E1 were 159.83 μg/mL and 261.40 μg/mL, respectively. The CYP2E1 activity was inhibited (IC50=215.17 μg/mL) higher than that other CYP450 isozymes by Taeumjowi-tang. Conclusions : These results suggest that Yangguksanhaw-tang may inhibit the metabolism of co-administered drugs whose primary route of metabolism is via CYP2C19 or CYP2E1. Taeumjowi-tang could inhibit the metabolism of co-administered drugs, which are substrates for CYP2E1. Therefore, co-administration of the herbal formulas and other conventional drugs should be undertaken with care.
참고문헌 (20)
- Chen XW, "Herb-drug interactions and mechanistic and clinical considerations", Curr Drug Metab, 13(5), pp.640~651 (2012)
- Lin CC, "Evaluation of chinese-herbal-medicine-induced herb-drug interactions : focusing on organic anion transporter 1", Evid Based Complement Alternat Med, 2012, pp.967182~ (2012)
- Bibi Z., "Role of cytochrome P450 in drug interactions", Nutr. Metab, 5, pp.27~ (2008)
- Takahashi K, "In vitro inhibitory effects of Kampo medicines on metabolic reactions catalyzed by human liver microsomes", J Clin Pharm Ther, 28(4), pp.319~327 (2003)
- 전국한의과대학 사상의학교실, "개정증보사상의학", pp.397~398 (2004), 집문당
- 전국한의과대학 사상의학교실, "개정증보사상의학", pp.415~ (2004), 집문당
- 정다영, "소양인 양격산화탕의 면역 활성화 연구", 사상체질의학회지, 22(4), pp.77~84 (2010), 사상체질의학회
- 이승엽, "소양인 형방도적산과 양격산화탕의 항 스트레스효과에 관한 실험적 연구", 사상체질의학회지, 20(3), pp.151~163 (2008), 사상체질의학회
- 김상진, "중풍으로 유발된 배뇨？배변장애에 양격산화탕을 위졸 한 치험 1례", 대한본초학회지, 18(3), pp.1~8 (2003), 대한본초학회
- Lo HS, "The effect of Yangkyuk-Sanhwa-tang on cytokine production in the patients with cerebral infarction", J. Sasang Constitut. Med., 16(1), pp.120~129 (2004)
- Lee GJ, "Effects of Taeyeumjoweetang on the obesity of mouse and induced adipocyte 3T3-L1", Kor. J. Orient. Med. Pathol., 10(1), pp.88~98 (1996)
- 김혜주, "태음조위탕의 적용이 태음인 비만여대생의 신체조성, 혈청지질농도 및 혈중 항산화 효소에 미치는 효과", 사상체질의학회지, 23(3), pp.391~401 (2011), 사상체질의학회
- Atterwill CK, "In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development", Toxicol. Lett., 127, pp.143~151 (2002)
- Iyanagi T, "Molecular mechanism of phase I and phase II drug-metabolizing enzymes : implications for detoxification", Int Rev Cytol., 260, pp.35~112 (2007)
- Shimada T, "Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals : studies with liver microsomes of 30 Japanese and 30 Caucasians", J Pharmacol Exp Ther, 270, pp.414~423 (1994)
- Snawder JE, "Interindividual variance of cytochrome P450 forms in human hepatic microsomes : correlation of individual forms with xenobiotic metabolism and implications in risk assessment", Regul Toxicol Pharmacol, 32(2), pp.200~209 (2000)
- Trubetskoy OV, "Highly Miniaturized Formats for In Vitro Drug Metabolism Assays Using Vivid® Fluorescent Substrates and Recombinant Human Cytochrome P450 Enzymes", J. Biomol. Screen, 10(1), pp.56~66 (2005)
- Xu Y, "Human pregnane X receptor-mediated transcriptional regulation of CYP3A4 by extracts of 7 traditional Chinese medicines", Zhongguo Zhong Yao Za Zhi, 36(11), pp.1524~1527 (2011)
- Yao HT, "Suppressive effect of the ethanolic extract of adlay bran on cytochrome P-450 enzymes in rat liver and lungs", J. Agric. Food Chem., 59(8), pp.4306~4314 (2011)
- Pereillo JM, "Structure and stereochemistry of the active metabolite of clopidogrel", Drug Metab. Dispos, 30(11), pp.1288~1295 (2002)